Company: LNAI
Filing Date: 2025-10-30
Form Type: 8-K
Source: 0001731122-25-001446
Chunk: 0

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-30
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01 Notice of Delisting
or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On October 27, 2025, Lunai Bioworks (the “ Company”)
received a notification letter (the “ Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq”)
indicating that the Company is not in compliance with the $35 million minimum Market Value of Listed Securities (“ MVLS”)
requirement set forth in Nasdaq Listing Rule 5550(b)(2) for Capital Market.

The Notice stated that the Company’s MVLS had
been below $35 million for the previous 30 consecutive business days, and that, in accordance with Nasdaq rules, the Company has a period
of 180 calendar days, or until April 27, 2026 to regain compliance.

To regain compliance, the Company’s MVLS must
close at $35 million or more for a minimum of 10 consecutive business days during the compliance period, at which time Nasdaq
will provide written confirmation that the deficiency has been cured and the matter is closed.

The Notice is not expected to have any immediate
effect on the listing or trading of the Company’s common stock, which will continue to trade on the Nasdaq Capital Market under
the symbol “ LNAI.”

If the Company does not regain compliance by the end
of the compliance period, Nasdaq will notify the Company that its securities are subject to delisting. At that time, the Company may appeal
the determination to a Nasdaq Hearings Panel, which would stay the delisting pending a decision by the Panel.

The Company intends to monitor its MVLS and may consider
available options, including potential corporate actions, to regain compliance within the prescribed compliance period.

Forward-Looking Statements